SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HYBN: Hybridon, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JMarcus11/28/2003 2:36:58 PM
   of 28
 
Earlier this week HYBN announced that it will begin trading on the AMEX on Friday, Dec. 5th. The company has certainly had a heady increase in news flow recently. If you search HYBN.OB's Headlines in Yahoo, you'll see that the only news from at least 10/24/02 until 9/2/03 was the SEC filings. Then on 9/2/03 they announced the $14.6M PIPE and the restructuring of the Series A stock, reducing the Series A's liquidation preference from $70M to a mere $388,260. Since then the news flow has gone into high gear.

I just listened to the Oct. 27th webcast (the website and the powerpoint presentation are both available through www.hybridon.com). The stock price closed at $1.00 on Oct. 24th, just prior to the presentation. In the presentation the CEO said that, fully diluted, the company's market cap was about $100M. He also said that once the anticipated conversions of Series A are completed, there should be about 73M shares outstanding. I guess that means that there must be about $27M worth of warrants and unconverted Series A stock still outstanding.

The CEO also said that the company has about $21M cash and almost no debt. The annual burn rate is $15M.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext